1. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients

   • Donald M. Lloyd-Jones

   Clinical Trials Report 01 July 2009 Pages: 233 - 234

2. Effects of exercise modality on insulin resistance and functional limitation in older adults

   • Vaughn W. Barry
   • Timothy Church
   • Steven N. Blair

   Clinical Trials Report 01 July 2009 Pages: 235 - 236

3. Hypertension therapy in the oldest patients

   • Nigel S. Beckett
   • Dean J. Noimark

   OriginalPaper 01 July 2009 Pages: 239 - 246

4. Risks of electrocardiographic left ventricular hypertrophy in hypertensive individuals and benefits of treatment-induced regression

   • Seth R. Bender
   • Richard B. Devereux
   • Peter M. Okin

   OriginalPaper 01 July 2009 Pages: 247 - 254

5. The role of ACE inhibitors and angiotensin receptor blockers in the treatment of hypertension and cardiovascular disease

   • J. Susie Woo
   • Jeffrey L. Probstfield

   OriginalPaper 01 July 2009 Pages: 255 - 263

6. Epidemiologic and pathophysiologic links between obesity and hypertension

   • Arlene L. Hankinson

   OriginalPaper 01 July 2009 Pages: 264 - 271

7. Physical activity interventions in minority populations

   • Dori Pekmezi
   • Ernestine Jennings

   OriginalPaper 01 July 2009 Pages: 275 - 280

8. Physical activity and cardiovascular disease risk factors in children and adolescents

   • Jonatan R. Ruiz
   • Francisco B. Ortega

   OriginalPaper 01 July 2009 Pages: 281 - 287

9. Physical activity in cardiovascular disease prevention in patients with HIV/AIDS

   • Gregory A. Hand
   • Jason R. Jaggers
   • Wesley D. Dudgeon

   OriginalPaper 01 July 2009 Pages: 288 - 295

10. The role of exercise interval training in treating cardiovascular disease risk factors

    • Conrad Earnest

    OriginalPaper 01 July 2009 Pages: 296 - 301

11. Does the built environment matter for physical activity?

    • Natalie Colabianchi

    OriginalPaper 01 July 2009 Pages: 302 - 307